Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Agilent Introduces Powerful Enhancements to Leading Life Science Software
Friday, October 31, 2014
New GeneSpring platform enables faster discovery of complex relationships across multi-omic data.

Roche NimbleGen Introduces Advanced RNA-Seq Target Enrichment Tools
Friday, October 31, 2014
The SeqCap RNA target enrichment system for in-depth transcriptome studies.

GE Healthcare Life Sciences’ Dharmacon Launches Innovative Gene Engineering Platform
Thursday, October 30, 2014
Novel toolset substantially decreases time needed to create permanent CRISPR-Cas9-induced genetic changes in cells.

PerkinElmer Launches Mantra™ Quantitative Pathology Imaging System
Tuesday, October 28, 2014
New imaging system enables researchers to visualize, quantify, analyze and phenotype multiple types of immune cells simultaneously in solid tumors.

Agilent Introduces Focused Exome Kit with Unparalleled Coverage, Speed, Flexibility for Disease Research
Monday, October 27, 2014
Solution Ideal for Both High-Throughput and Benchtop Next-Generation Sequencing Applications.

Agilent Introduces SureSelect Focused Exome Kit
Saturday, October 25, 2014
Solution ideal for both high-throughput and benchtop next-generation sequencing applications.

Horizon Discovery Group Launches Xenograft Models of Breast Cancer
Thursday, October 23, 2014
Largest available collection of PDX cell lines, faithfully modelling human breast cancers.

BioDiscovery Launches NxClinical™ Software
Wednesday, October 22, 2014
A unique solution for complete case review and reporting for genetics labs.

Illumina Launches New Reagent Kits for HiSeq X Ten and HiSeq 2500 Systems
Saturday, October 18, 2014
Enhancements offer improved performance for high throughput sequencing.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2535
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv